Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What is vascular dementia?

A F Kurz1

  • 1Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany.

International Journal of Clinical Practice. Supplement
|June 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease.

European journal of neurology·2003
Same author

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.

Dementia and geriatric cognitive disorders·2001
Same author

Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers.

Clinical therapeutics·2001
See all related articles

Cerebrovascular disease (CVD) can cause vascular dementia (VaD) through various mechanisms, including cortical lesions and white matter damage. Distinguishing VaD from other dementias requires understanding its diverse pathological and pathogenetic pathways.

Area of Science:

  • Neurology
  • Geriatrics
  • Pathology

Background:

  • Cerebrovascular disease (CVD) and dementia frequently co-occur in elderly individuals.
  • Traditional dementia definitions focused on intellectual decline, while revised definitions emphasize global deficits and impact on activities of daily living (ADL).
  • Applying revised dementia definitions to CVD presents challenges due to focal lesions and physical symptoms complicating ADL assessment.

Purpose of the Study:

  • To explore the relationship between cerebrovascular disease (CVD) and dementia, specifically vascular dementia (VaD).
  • To elucidate the pathogenetic mechanisms by which CVD can lead to global cognitive impairment.
  • To highlight the need for distinguishing distinct VaD syndromes.

Main Methods:

  • Review of existing literature on cerebrovascular disease and dementia.

Related Experiment Videos

  • Analysis of pathogenetic mechanisms linking vascular lesions to cognitive deficits.
  • Comparison of neurobehavioural symptoms in CVD with those in Alzheimer's disease.

    • Main Results:

    • Focal cortical lesions in CVD cause location-specific deficits, not typically global intellectual decline.
    • Subcortical lesions and white matter damage are common in CVD, leading to distinct neurobehavioural symptoms.
    • Mechanisms like accumulated ischemic lesions, strategic infarcts, and white matter disconnection can cause global cognitive impairment and meet VaD criteria.

    Conclusions:

    • Vascular dementia (VaD) arises from diverse etiological factors, pathological changes, and pathogenetic mechanisms.
    • Distinct VaD syndromes need to be identified to improve diagnosis and treatment.
    • Further research is necessary to validate the concept of distinct VaD syndromes and their clinical utility.